Table 1. Patient sample characteristics.
| % Nucleated cells | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ID | Karyotype | Age (y) | Sex | Disease status | MRD risk status | CD34+/CD99+ | CD34+/CD99- | CD34-/CD99+ | CD34-/CD99- |
| 1 | iso 9, +4 | 15 | M | Relapse | Risk | 1.70 | 0.80 | 95.00 | 2.50 |
| 2 | t(11;14) | 2 | M | Relapse | Low | 1.19 | 0.22 | 91.45 | 7.14 |
| 3 | t(9;16),+7,-9 | 5 | M | Relapse | Risk | 2.70 | 1.80 | 78.90 | 16.60 |
| 4 | 46 XY | 17 | M | Diagnosis | Risk | 58.10 | 1.34 | 29.30 | 11.26 |
| 5 | t(1;14) | 10 | M | Diagnosis | Low | 0.42 | 0.02 | 96.28 | 3.28 |
| 6 | del 6q | 15 | M | Diagnosis | Risk | 90.60 | 0.81 | 3.97 | 4.62 |
| 7 | +1, del 6, del11 | 2 | F | Diagnosis | N/A | 0.09 | 0.01 | 64.7 | 35.2 |
| 8 | 46 XY | 3 | M | Diagnosis | Risk | 0.11 | 0.07 | 87.5 | 12.32 |
| 9 | complex | 6 | M | Diagnosis | Low | 0.01 | 0.01 | 90.7 | 9.28 |
N/A, not available.